Scott Halsted
Mr. Halsted is a Managing Partner at Revelation Partners. Prior to co-founding Revelation Partners, he was a Managing Director at Saints Capital where he lead the company's healthcare investment activities. He spearheaded several portfolio transactions including the purchase of 52 investments from Boston Scientific, the restructuring of the Oxford Bioscience Funds III & IV, the purchase of the Alta Partners II fund, and several individual company investments.
Mr. Halsted was previously a Managing Member at Morgan Stanley Ventures, where he worked from 1987 to 2007. As co-head of the health care practice at Morgan Stanley Ventures, Mr. Halsted managed over $300 million of investments in over 40 companies. Prior to his investment career, Mr. Halsted worked in the medical technology field in the areas of product design and business development for Intermedics Orthopedics and Hexcel Medical.
Mr. Halsted’s investments include many successful companies including: Intuitive Surgical, Incline Therapeutics, Ekos Corporation, Astex Pharmaceuticals, MediGuide, eValve, Enanta Pharmaceuticals, Concentric, MileStone Healthcare, Arcadian Health, BenefitMall, Microgenics, Rita Medical, Cytyc Corporation, Managed Health Networks, and R2 Technology.
Mr. Halsted is currently on the boards of AngioScore, DiscoveRx, InnFocus.